Skip to search formSkip to main contentSkip to account menu

CCI 17810

Known as: CCI-17810, Piperazine, 1-(phenylacetyl)-4-(4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl)- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
[Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones].
To search for more ideal antithrombotic drugs sixteen 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones were designed and… 
1981
1981
EFFECTS OF 6‐[p‐(4‐PHENYLACETYLPIPERAZIN‐1‐YL)PHENYL]‐4,5‐DIHYDRO‐3(2H)PYRIDAZINONE (CCI 17810) AND ASPIRIN ON PLATELET AGGREGATION AND ADHESIVENESS
1 The effects of 6‐[p‐(4‐phenylacetylpiperazin‐1‐yl)‐phenyl]‐4,5‐dihydro‐3(2H)pyridazinone (CCI 17810) on platelet aggregation… 
1980
1980
Effects of 6-[p-(4-Phenylacetylpiperazin-l-yl)-phenyl]-4,5-Dihydro-3(2H)-Pyridazinone (CCI 17810) and Aspirin on Experimental Arterial Thrombosis in Rats
Summary An experimental model for arterial thrombosis has been investigated in rats. A loop of polythene tubing inserted in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)